A detailed history of Frazier Life Sciences Management, L.P. transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Frazier Life Sciences Management, L.P. holds 3,760,457 shares of BBIO stock, worth $104 Million. This represents 5.15% of its overall portfolio holdings.

Number of Shares
3,760,457
Previous 3,632,604 3.52%
Holding current value
$104 Million
Previous $92 Million 4.05%
% of portfolio
5.15%
Previous 5.42%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$23.91 - $31.3 $3.06 Million - $4 Million
127,853 Added 3.52%
3,760,457 $95.7 Million
Q2 2024

Aug 15, 2024

BUY
$23.0 - $31.04 $4.99 Million - $6.74 Million
217,000 Added 6.35%
3,632,604 $92 Million
Q1 2024

May 15, 2024

BUY
$27.35 - $40.45 $18.9 Million - $27.9 Million
689,655 Added 25.3%
3,415,604 $106 Million
Q3 2023

Nov 14, 2023

BUY
$16.89 - $35.01 $12.4 Million - $25.8 Million
737,073 Added 37.06%
2,725,949 $71.9 Million
Q2 2023

Aug 14, 2023

BUY
$13.29 - $18.01 $10.9 Million - $14.7 Million
817,226 Added 69.75%
1,988,876 $34.2 Million
Q1 2023

May 15, 2023

BUY
$7.17 - $18.55 $8.4 Million - $21.7 Million
1,171,650 New
1,171,650 $19.4 Million

Others Institutions Holding BBIO

About BridgeBio Pharma, Inc.


  • Ticker BBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 148,246,000
  • Market Cap $4.12B
  • Description
  • BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...
More about BBIO
Track This Portfolio

Track Frazier Life Sciences Management, L.P. Portfolio

Follow Frazier Life Sciences Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Frazier Life Sciences Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Frazier Life Sciences Management, L.P. with notifications on news.